Literature DB >> 7608483

Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis.

H Komeichi1, R Moreau, S Cailmail, C Gaudin, D Lebrec.   

Abstract

BACKGROUND/AIMS: The effects of C-type and brain natriuretic peptides (CNP and BNP, respectively) on renal excretion of sodium and hemodynamics have not yet been studied in cirrhosis.
METHODS: This study aimed to examine the effects of saline, CNP (300 ng.kg-1.min-1 i.v. for 30 min) and BNP (600 ng.kg-1.min-1 i.v. for 30 min) on natriuresis and diuresis in normal and rats with cirrhosis. Moreover, regional and systemic hemodynamics were measured prior to and following CNP and BNP administration in normal rats and rats with cirrhosis with ascites.
RESULTS: In rats with cirrhosis, the effects of CNP or BNP or natriuresis and diuresis did not significantly differ from the effects of saline. CNP significantly decreased portal pressure and systemic vascular resistance and significantly increased the cardiac index. BNP significantly decreased portal tributary blood flow, portal pressure and cardiac index. In normal rats, natriuresis and diuresis were significantly higher with CNP and BNP than with saline. Systemic hemodynamics were not changed by CNP. A decrease in arterial pressure was the sole BNP-induced hemodynamic change.
CONCLUSIONS: In conclusion, this study shows that the natriuretic response to pharmacological doses of CNP and BNP is blunted in rats with cirrhosis. This blunting may be related to an activation of the endogenous antinatriuretic systems secondary to systemic vasodilation (by CNP) or to a decreased cardiac index (by BNP). Finally, this study shows that CNP and BNP have a portal hypotensive action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608483     DOI: 10.1016/0168-8278(95)80285-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure.

Authors:  V Gülberg; S Møller; J H Henriksen; A L Gerbes
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 3.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

4.  New insight into the role of NT-proBNP in alcoholic liver cirrhosis as a noninvasive marker of esophageal varices.

Authors:  Neven Ljubicić; Marija Gomercić; Drazen Zekanović; Tomislava Bodrozić-Dzakić; Ana Duzel
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

5.  NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.

Authors:  Anna Licata; Salvatore Corrao; Salvatore Petta; Chiara Genco; Mauro Cardillo; Vincenza Calvaruso; Giuseppe Cabibbo; Fatima Massenti; Calogero Cammà; Giuseppe Licata; Antonio Craxì
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.